Miniaturized, ultra-high throughput screening of tyrosine kinase using homogeneous, competitive fluorescence immunoassays

Assay and Drug Development Technologies

Volumn 2, Issue 2, 2004, Pages 141-151

  Beasley, James R ^a   McCoy, Paul M ^a   Walker, Tiffany L ^a   Dunn, David A ^a  

^a PHARMACOPEIA INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE;

ARTICLE; CHEMICAL PARAMETERS; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC KIT; ENZYME IMMUNOASSAY; FLUORESCENCE POLARIZATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; FLUOROMETRY; HIGH THROUGHPUT SCREENING; IMMUNOFLUORESCENCE; INTERMETHOD COMPARISON; QUALITY CONTROL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

EID: 2442482366     PISSN: 1540658X     EISSN: None     Source Type: Journal    
DOI: 10.1089/154065804323056486     Document Type: Article

References (17)

1. Daucey J, Sausville EA: Issues and progress with protein kinase inhibitors for cancer treatment. Nat Rev Drug Discov 2003;2:296-313.
2. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S: The protein kinase complement of the human genome. Science 2002;298:1912-1934.
3. Burke TJ, Loniello KR, Beebe JA, Ervin KM: Development and application of fluorescence polarization assays in drug discovery. Comb Chem High Throughput Screen 2003;6:183-194.
4. Park Y-W, Cummings RT, Wu L, Zheng S, Cameron PM, Woods A, Zaller DM, Marcy AI, Hermes JD: Homogeneous proximity tyrosine kinase assays: scintillation proximity assay versus homogeneous time-resolved fluorescence. Anal Biochem 1999;269:94-104.
5. Eggeling C, Brand F, Ullmann D, Jäger S: Highly sensitive fluorescence detection technology currently available for HTS. Drug Discov Today 2003;8:332-341.
6. Glenney JR Jr, Zokas L: Novel tyrosine kinase substrates from Rous sarcoma virus-transformed cells are present in the membrane skeleton. J Cell Biol 1989;108:2401-2408.
7. Zhang J-H, Chung TDY, Oldenberg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4:67-73.
8. Auld DS, Dunn DA, Lehrach JM, McCoy P, Swanson R: 1,536-well assay development and screening using whole cell displacement binding and laser scanning imaging. Assay Drug Dev Technol 2003;1:167-174.
9. Eglen RM: Enzyme fragment complementation: a flexible high throughput screening assay technology. Assay Drug Dev Technol 2002;1:97-104.
10. Zaman GJR, Garritsen A, de Boer T, van Boeckel CAA: Fluorescence assays for high-throughput screening of protein kinases. Comb Chem High Throughput Screen 2003; 6:313-320.
11. Kolb AJ, Kaplita PV, Hayes DJ, Park Y-W, Pernell C, Major JS, Mathis G: Tyrosine kinase assays adapted to homogeneous time-resolved fluorescence. Drug Discov Today 1998;3:333-342.
12. Wu G, Yuan Y, Hodge CN: Determining appropriate substrate conversion for enzymatic assays in high-throughput screening. J Biomol Screen 2003;8:694-700.
13. McGovern SL, Caselli E, Grigorieff N, Shoichet BK: A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J Med Chem 2002;45:1712-1722.
14. Sills MA, Weiss D, Pham Q, Schweitzer R, Wu X, Wu JJ: Comparison of assay technologies for a tyrosine kinase assay generates different results in high throughput screening. J Biomol Screen 2002;7:191-214.
15. Gaudet EA, Huang KS, Zhang Y, Huang W, Mark D, Sportsman JR: A homogeneous fluorescence polarization assay adaptable for a range of protein serine/threonine and tyrosine kinases. J Biomol Screen 2003;8:164-175.
16. Adams C, Boge A, Gaudet L: HTS platform for determining enzyme activity. Genet Eng News 2003;23:1.
17. Wright PA, Boyd HF, Bethell RC, Busch M, Gribbon P, Kraemer J, Lopez-Calle E, Mander TH, Winkler D, Benson N: Development of a 1-μ l scale assay for mitogen-activated kinase kinase 7 using 2-D fluorescence intensity distribution analysis anisotropy. J Biomol Screen 2002;7:419-428.